Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
16.27
7.44
45.73%
Share Warrants & Outstandings
Total Reserve
0.95
2.51
-1.56
-62.15%
Shareholder's Funds
24.65
18.78
5.87
31.26%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.33
-0.33
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.33
-0.33
-100.00%
Current Liabilities
Trade Payables
0.00
30.99
-30.99
-100.00%
Other Current Liabilities
0.14
0.18
-0.04
-22.22%
Short Term Borrowings
0.44
0.47
-0.03
-6.38%
Short Term Provisions
0.00
0.21
-0.21
-100.00%
Total Current Liabilities
0.57
31.85
-31.28
-98.21%
Total Liabilities
25.23
50.96
-25.73
-50.49%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
11.75
-11.70
-99.57%
Less: Accumulated Depreciation
0.01
3.41
-3.40
-99.71%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
8.34
-8.30
-99.52%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.02
0.00
0.02
0.00%
Other Non Current Assets
0.00
0.06
-0.06
-100.00%
Total Non-Current Assets
0.07
8.41
-8.34
-99.17%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
3.34
-3.34
-100.00%
Sundry Debtors
0.60
38.31
-37.71
-98.43%
Cash and Bank
21.30
0.26
21.04
8,092.31%
Other Current Assets
0.00
0.05
-0.05
-100.00%
Short Term Loans and Advances
3.26
0.59
2.67
452.54%
Total Current Assets
25.16
42.55
-17.39
-40.87%
Net Current Assets (Including Current Investments)
24.59
10.71
13.88
129.60%
Total Current Assets Excluding Current Investments
25.16
42.55
-17.39
-40.87%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
50.96
-25.73
-50.49%
Contingent Liabilities
0.49
0.00
0.49
0.00%
Total Debt
0.44
0.47
-0.03
-6.38%
Book Value per share (adjusted)
10.40
11.54
-1.14
-9.88%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024






